Intec Pharma Announces $10 Million Ordinary Shares Purchase Agreement With Aspire Capital
- Tuesday, December 3, 2019, 7:41
- Environment
- Add a comment
JERUSALEM, Dec. 3, 2019 /PRNewswire/ — Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that the Company has entered into an Ordinary Shares Purchase Agreement for $10.0 million with Aspire Capital Fund, LLC (“Aspire Capital”), a Chicago-based institutional…
About the Author
adminasapcorp has written 39125 stories on this site.